Simon was Chief Investment Officer at Metagenomi Therapeutics, and Chief Investment Officer at Cellectis. Simon Harnest joined Totus Medicines in 2025.
Simon Harnest is currently
Create your alert
to follow the career of Simon Harnest.
Do you need to know more about Simon Harnest? More results.
Report an error
Update the org chart details of Simon Harnest.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.